One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial

Marti, Joachim; Hall, Peter; Hamilton, Patrick; Lamb, Sarah; McCabe, Chris; Lall, Ranjit; Darbyshire, Julie; Young, Duncan; Hulme, Claire

doi:10.1186/s40560-016-0178-8

Journal of Intensive Care

Table 5 Resource use in subgroups of patients with ARDS (mean [SD])

From: One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial

	All patients						1-year survivors
	n	ICU cost £	ICU los days	Hosp. cost £	Hosp. los days	Total societal cost^a £	n	ICU cost £	ICU los days	Hosp. cost £	Hosp. los days	Total societal cost^a £
Age (years)
<65	540	28,173 [1040]	17.8 [0.72]	40,080 [1802]	35.6 [1.8]	46,882 [1817]	318	30,808 [1262]	19.9 [0.87]	47,470 [2465]	45.3 [2.50]	55,041 [2494]
≥65	255	24,070 [1381]	15.6 [1.00]	32,429 [2153]	28.6 [2.2]	38,135 [2172]	70	28,376 [2380]	19.2 [1.85]	46,175 [4023]	52.4 [4.64]	53,481 [4137]
Gender
Male	495	25,715 [969]	16.3 [0.67]	37,017 [1780]	31.9 [1.57]	43,728 [1804]	240	28,786 [1220]	18.7 [0.85]	46,603 [2719]	45.5 [2.45]	54,425 [2771]
Female	300	28,740 [1530]	18.4 [1.09]	38,630 [2315]	35.8 [2.76]	44,652 [2323]	148	32,938 [2156]	21.5 [1.54]	48,263 [3498]	48.4 [4.26]	55,302 [3517]
APACHE II score
<26	577	27,160 [917]	17.3 [0.63]	38,740 [1634]	35,3 [1.73]	45,171 [1647]	310	30,058 [1224]	19.7 [0.87]	47,035 [2401]	46.8 [2.5]	54,520 [2423]
≥26	188	26,167 [1909]	16.7 [1.36]	34,226 [2979]	27.9 [2.65]	40,680 [3030]	59	34,338 [3282]	21.8 [2.3]	52,160 [5985]	50.54 [5.85]	59,962 [6194]
PaO2:FiO2 ratio (KPa)
<15	433	26,271 [1209]	16.6 [0.85]	35,518 [1897]	29.5 [1.78]	41,958 [1926]	183	32,718 [1828]	20.9 [1.3]	50,357 [3255]	45.3 [2.9]	58,010 [3292]
≥15	362	27,557 [1134]	17.8 [0.79]	40,146 [2104]	38.0 [2.28]	46,611 [2110]	205	28,273 [1340]	18.7 [0.94]	44,450 [2827]	47.8 [3.3]	51,857 [2872]
Prime condition
Pneumonia	466	26,245 [1022]	16.7 [0.71]	36,356 [1874]	29.9 [1.6]	42,537 [1882]	220	29,987 [1380]	19.4 [0.95]	46,480 [3098]	41.7 [2.6]	53,629 [2921]
Other	329	27,723 [1410]	17.8 [1.0]	39,424 [2138]	38.3 [2.5]	46,257 [2174]	168	30,871 [1853]	20.1 [1.3]	48,227 [2849]	53.1 [3.8]	56,239 [2921]
Surgery admission
No	687	26,883 [892]	17.1 [0.62]	37,104 [1506]	32.0 [1.5]	43,495 [1519]	324	30,700 [1194]	19.9 [0.83]	47,135 [2406]	45.2 [2.4]	54,579 [2440]
Yes	108	26,690 [2404]	17.4 [1.7]	40,942 [4015]	42.1 [4.7]	47,779 [4065]	64	28,695 [3106]	18.9 [2.26]	47,752 [4584]	53.9 [5.61]	55,672 [4636]
Ventilation method
Conventional	397	25,606 [1110]	16.3 [0.76]	36,148 [1756]	32.5 [1.9]	42,489 [1764]	194	28,588 [1519]	18.3 [1.02]	44,343 [2499]	44.5 [2.96]	51,842 [2522]
HFOV	398	28,105 [1249]	18.0 [0.89]	39,100 [2207]	34.2 [2.1]	45,660 [2234]	194	32,151 [1639]	21.2 [1.20]	50,130 [3480]	48.7 [3.30]	57,677 [3536]
ICU los (1-year survivors)
≤15	–	–	–	–	–	–	198	–	–	29,071 [1792]	28.7 [1.76]	36,330 [1826]
>15	–	–	–	–	–	–	190	–	–	66,166 [3468]	65.4 [3.67]	73,965 [3509]

^aTotal societal costs estimates based on imputed data for patients with missing post-hospital cost

Back to article page

ISSN: 2052-0492

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com